FDA
approval
· 2023-05-01
FDA Approved: DALFAMPRIDINE — Supplemental Application (Aurobindo Pharma Limited)
Summary
FDA approved a supplemental application for dalfampridine from Aurobindo Pharma Limited, enabling a generic version of the drug. This action formalizes the appr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DALFAMPRIDINE (DALFAMPRIDINE)